Genemedi produces core diagnostic ingredients for test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome. GeneMedi offers paired diagnostics grade alpha defensin 5 (α-defensin 5) antibodies (monoclonal antibody, mab) and antigens for Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) rapid test kit of alpha defensin 5 (α-defensin 5) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI) ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Alpha defensins are a family of mammalian defensin peptides of the alpha subfamily. Prosthetic joint infection (PJI) management is not standardized worldwide. Diagnosis of PJI remains challenging because the clinical signs and symptoms and elevation of systemic biomarkers (C-reactive protein, erythrocyte sedimentation rate) may be unclear. Synovial biomarkers have shown encouraging results and they should be used as diagnostic adjuncts to synovial white cell count and culture bacteriology. Synovial leukocyte esterase (LE) and synovial C-reactive protein (CRP) have been evaluated as good screening measures; however, the most promising synovial fluid biomarker in terms of sensitivity and specificity for PJI seems to be alpha defensin (AD). alpha defensin lateral flow test could have its place in ruling in a suspected PJI intraoperatively because of its high specificity and rapid results.